NMTC

$2.01+$0.18 (+9.84%)live

Compare

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Market cap

$13.2M

9M shares

52-week range

$1.42 – $6.96

11% from low

Sector

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Exchange

NASDAQ

Change$-27.63

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$11M	+20.0%	$-1.28	$-1.37–$-1.18	—	1
2027	$15M	+36.1%	$-1.45	$-1.55–$-1.33	—	2
2028	$22M	+50.8%	$-0.72	$-2.67–$1.23	—	2
2029	$29M	+31.0%	$0.35	$0.32–$0.37	5.7×	1

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Earnings surprises

Beat consensus in 5 of the last 8 reported quarters

Reported	Est. EPS	Actual	Surprise
2026-08-13	$-0.57	$-0.28	+51.2%
2026-05-12	$-0.23	$-0.25	-10.3%
2026-02-17	$-0.24	$-0.18	+25.0%
2025-12-17	$-0.04	$-0.05	-25.0%
2025-08-14	$-0.05	$-0.03	+40.0%
2025-05-13	$-0.09	$-0.07	+22.2%
2025-02-12	$-0.10	$0.06	+160.0%
2024-12-17	$-0.09

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
NMTCNeuroOne Medical Technologies Corporation	$1.83	+18.83%	$16M	—
ATHEAlterity Therapeutics Limited	$4.70	-4.28%	$80M	—
BDMDBaird Medical Investment Holdings Limited	$1.14	-3.39%	$48M	—
CTSOCytosorbents Corporation	$0.36	-2.08%	$23M	—
ECORelectroCore, Inc.	$9.94

NeuroOne Medical Technologies Corporation Common Stock

NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.

www.n1mtc.com

Employees: 18
IPO / List date: Nov 9, 2012
HQ: EDEN PRAIRIE, MN

Held by traders on TradeandTell

No one on the platform currently holds NMTC.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in NMTC as of their last filing.

Insider activity (SEC Form 4)

Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.

Insider activity (SEC Form 4)

Stock splits

Execution date	Ratio
2026-04-16	1-for-6reverse
2021-04-01	1-for-3reverse

Recent trades on TradeandTell

No one on the platform has traded NMTC yet.

$NMTC chatter on StockTwits

NeuroOne Medical IR@NeuroOne_IR1h
$NMTC NeuroOne’s pipeline builds on a technology platform that has already progressed from development to FDA-cleared applications. Today, our portfolio includes four FDA-cleared product families spanning diagnostic recording and radiofrequency ablation, providing a foundation for expanding our core electrode technology into new therapeutic applications. Our pipeline includes StereoCED™ for targeted drug delivery, basivertebral nerve ablation (BVNA) for back pain and potential spinal cord stimulation (SCS) — each representing a new application of the broader NeuroOne platform. Our goal is to continue expanding that platform to support more precise, minimally invasive approaches across neurological and chronic pain care.
View on StockTwits ↗
Marianne V@MarianneV6h
$NMTC
View on StockTwits ↗
Marianne V@MarianneV16h
$NMTC A lot to digest and discuss after the ER, but interesting to see the business has evolved to the point that a major problem is actually getting product out to meet the demand.
View on StockTwits ↗
Damian@ZephixBullish17h
$NMTC Win
View on StockTwits ↗
DeFa@StockShockFever19h
$NMTC It is ABOUT TIME that someone from NMTC posted actual FACTS on this board instead of just letting retail investors here post, what many times have been nonsense based on almost nothing. People need facts and data and updates, not just fluff and hype and blind hope. For Incognito and Marianne this at least gives them some real hope, which they kind of deserve due to sticking by you all this time.
View on StockTwits ↗
NeuroOne Medical IR@NeuroOne_IR19h
$NMTC At NeuroOne, our mission is to develop minimally invasive technologies designed to improve how neurological conditions are diagnosed and treated. Today, that mission is supported by a growing portfolio that includes FDA-cleared technologies, commercially available products and a pipeline of new applications being developed from our core electrode platform. Our work spans both diagnostic and therapeutic uses, with the goal of creating technologies that can make neurological procedures more precise, efficient and less invasive. Through this channel, we will be sharing updates around our technology, commercial progress, pipeline and the milestones shaping our growth. We look forward to hearing from the investors following our story. Join the conversation, your voice matters.
View on StockTwits ↗
jorge .miguel@focafoca991d
$NMTC released its third fiscal quarter results for the quarter ended June 30, 2026.
View on StockTwits ↗
Stocktwits Earnings@StocktwitsEarnings1d
$NMTC Q3 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.23 down -27.78% YoY • Reported revenue of $1.97M up 16.34% YoY • NeuroOne Medical Technologies Corporation expects fiscal year 2026 recognized revenue to range from $9.2 million to $10.5 million, depending primarily on manufacturing completion and the timing of product shipments.
View on StockTwits ↗
Kat@IncognitoBullBullish2d
$NMTC
View on StockTwits ↗
Marianne V@MarianneV2d
$NMTC
View on StockTwits ↗
Michael Smit@Wisenheimer3d
$NMTC anyone think they may have lost Zimmer?
View on StockTwits ↗
Jose Berrios@dario2580Bullish6d
$NMTC FDA/clinical catalysts can move the stock sharply🚀
View on StockTwits ↗
Marianne V@MarianneVAug 7
$NMTC
View on StockTwits ↗
DeFa@StockShockFeverAug 6
$NMTC There seems to be a pattern. Believers post articles that are almost meaningless to NMTC and the stock price goes down. This may dive down after earnings?
View on StockTwits ↗
Michael Smit@WisenheimerAug 6
$NMTC I think whats going on is a potential “going concern” issue w virtually no cash left given burn and need to show probably at least 8mm in cash before the 09/30 yr end filing - should have opted for the 12/1 vs 6/1 reverse
View on StockTwits ↗

Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.